Oxcarbazepine
Oxtellar, Trileptal (oxcarbazepine) is a small molecule pharmaceutical. Oxcarbazepine was first approved as Oxtellar on 2000-01-14. It is used to treat epilepsy and partial epilepsies in the USA. Trileptal's patent is valid until 2027-04-13 (FDA).
| Trade Name | Oxtellar, Trileptal |
|---|---|
| Common Name | Oxcarbazepine |
| Indication | epilepsy, partial epilepsies |
| Drug Class | Tricyclic compounds |
